Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is the larger of the two by market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| INDV | IONS | |
|---|---|---|
Market Cap | $4.18B | $7.04B |
Volume | 1,819,746 | 2,977,440 |
Sector | Health | Health |
52-Week High | $41.83 | $86.50 |
52-Week Low | $24.09 | $42.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $6.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
